UniProtKB/SwissProt variant VAR

Variant information

Variant position:

179

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Histidine (H) to Tyrosine (Y) at position 179 (H179Y, p.His179Tyr).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and polar (H) to large size and aromatic (Y)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In LFS; germline mutation and in sporadic cancers; somatic mutation.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs587780070 [ dbSNP | Ensembl ]

Sequence information

Variant position:

179

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

393

The length of the canonical sequence.

Location on the sequence:

AMAIYKQSQHMTEVVRRCPH H ERCSDSDGLAPPQHLIRVEG

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         AMAIYKQSQHMTEVVRRCPHHERCSD-SDGLAPPQHLIRVEG

                              AMAIYKKSEFVTEVVRRCPHHERCSDSSDGLAPPQHLIRVE

Rhesus macaque                AMAIYKQSQHMTEVVRRCPHHERCSD-SDGLAPPQHLIRVE

Mouse                         AMAIYKKSQHMTEVVRRCPHHERCSD-GDGLAPPQHLIRVE

Rat                           AMAIYKKSQHMTEVVRRCPHHERCSD-GDGLAPPQHLIRVE

Pig                           AMAIYKKSEYMTEVVRRCPHHERSSDYSDGLAPPQHLIRVE

Bovine                        AMAIYKKLEHMTEVVRRCPHHERSSDYSDGLAPPQHLIRVE

Rabbit                        AMAIYKKSQHMTEVVRRCPHHERCSD-SDGLAPPQHLIRVE

Sheep                         AMAIYKKLEHMTEVVRRSPHHERSSDYSDGLAPPQHLIRVE

Cat                           AMAIYKKSEFMTEVVRRCPHHERCPDSSDGLAPPQHLIRVE

Chicken                       AVAVYKKSEHVAEVVRRCPHHERCGGGTDGLAPAQHLIRVE

Xenopus laevis                ATAVYKKSEHVAEVVKRCPHHERSVEPGEDAAPPSHLMRVE

Zebrafish                     ATAIYKKSEHVAEVVRRCPHHERTPD-GDNLAPAGHLIRVE

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 393	Cellular tumor antigen p53
DNA binding	102 – 292
Region	1 – 320	Interaction with CCAR2
Region	100 – 370	Interaction with HIPK1
Region	100 – 300	Required for interaction with ZNF385A
Region	113 – 236	Required for interaction with FBXO42
Region	116 – 292	Interaction with AXIN1
Metal binding	176 – 176	Zinc
Metal binding	179 – 179	Zinc
Modified residue	183 – 183	Phosphoserine; by AURKB
Mutagenesis	183 – 183	S -> A. Abolishes strongly phosphorylation.
Mutagenesis	183 – 183	S -> E. Inhibits slightly its transcriptional activity.
Helix	177 – 180

Literature citations

No reference for the current variant in UniProtKB/Swiss-Prot.

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P04637: Variant p.His179Tyr